significant predictors of all-cause mortality (hazard ratios: APN, 5.02; p < 0.001; CRP, 3.43, p < 0.001). The rate of ACS recurrence was significantly associated with APN levels. However, the other biomarkers did not show relationships with ACS recurrence. Multivariate analyses adjusted for APN, age, body mass index, diabetes, hypertension, smoking, and dyslipidemia identified the median and highest tertile of APN levels as the only predictors of ACS recurrence (hazard ratios: median, 4.46, p = 0.024; highest, 6.63, p = 0.005). Conclusions: Among the established biomarkers related to patient prognosis, APN was the most useful predictor of all-cause mortality and ACS recurrence.
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Identification of predictors of 1-year mortality after ST-elevation myocardial infarction-results from the Bremen STEMI-registry
Background: While the significance of cardiovascular risk factors for the pathogenesis of coronary artery disease (CAD) is well established their value as predictors of mortality remains unclear. Aim of this study was the identification of predictors for 1-year mortality after ST-elevation myocardial infarction (STEMI). Methods: All patients (pts) with STEMI from the metropolitan area of Bremen/Germany are admitted to the Bremen heart center and documented in the Bremen STEMI-registry (BSR). Pts with STEMI between 2006 and 2010 were analysed with regard to their 1-year-mortality using univariate, multivariate as well as age-matching statistical models.
Abstract P1317 - Table 1 Acute heart failure Age >65 were associated with an elevated 1-year mortality. In a multivariate model however only age, acute hf, LCMA stenosis and kidney disease were independent predictors of 1-year-mortality after STEMI while the influence of smoking, obesity, gender and diabetes mellitus did not show any significance. Non-smokers (69 yrs. vs 56 yrs), women (69 vs. 61 yrs), non-obese (64 vs. 60 yrs) and diabetic (67 vs. 62) pts were on average older than their counterparts at onset of STEMI. When directly age matching these groups (non-smokers vs smokers etc.) no differences in 1-year-mortality could be shown. The univariately shown elevated 1-year-mortality after STEMI in women, non-smokers, non-obese and diabetic patients can thus mainly be attributed to the advanced age at onset of STEMI. Conclusions: These data suggest that in contrast to age, acute heart failure, kidney disease and LCMA stenosis classical risk factors for CAD like diabetes mellitus, smoking and an elevated BMI did not qualify as independent predictors for 1 year mortality after STEMI.
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Utility of wearable cardioverter defibrillators in European patients early after myocardial infarction
N. Bianco, S. Szymkiewicz. ZOLL, Pittsburgh, United States of America Background: Post-myocardial infarction (MI) and post-revascularization patients (pts) with low ejection fractions (EF) can be protected from death due to sudden cardiac arrest (SCA) immediately post-discharge with a wearable cardioverter defibrillator (WCD) until decisions on long-term risk management can reasonably be formulated. This study examines the utility of providing a WCD to European pts identified by their caregivers to be at high risk for SCA during these waiting periods. Methods: The European WCD medical order database was searched for pts who were coded as "recent MI with EF≤35%" or "recent revascularization with EF≤35%", then matched to device-recorded data. Only pts who completed or ended use, and wore the WCD for ≥15 minutes were used for this analysis. SCA was defined as all sustained ventricular tachycardia/fibrillation (VT/VF) or asystole occurring within 24 hours of the index arrhythmia. WCD resuscitation was defined as regaining consciousness after treatment for SCA. Results: Between 2/2010 and 12/2012, 576 unique pts matched study criteria. Pts (age 60±12 years, 85% male) wore the WCD for a median of 51 days. The WCD appropriately treated 13 pts for VT/VF. No asystole events occurred during use. Resuscitation success was 100%. The median time to SCA was 15 days after initiating WCD use. Conclusions: SCA occurred in 2.3% of pts having a compromised EF after MI and/or revascularization, and the majority of SCA occurred during the first month of use. The WCD resuscitated 100% of pts that experienced SCA. 
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In-hospital outcomes and long-term mortality according to gender and management strategy in acute myocardial infarction. Insights from the FAST-MI 2005 registry
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matically decreased in the recent past. Whether the previously reported gender disparities in use of invasive strategies (IS) persist and translate into differences in outcomes deserves to be examined. Methods: We used the data from a nationwide French prospective multicentre registry from 3,670 AMI patients (1155 women (31.5%), 2515 men (68.5%)) recruited in 223 centers in 2005 and followed-up for 3 years. We examined inhospital outcomes and 3-year mortality in patients categorized according to gender and use of IS (i.e. coronary angiography during the hospitalisation with a view to revascularisation). Results: IS was less frequently used in women than in men (adjusted OR=0.66; 95% CI: 0.52-0.85), regardless of the type of AMI, age group or risk category, while use of recommended medications was similar at 48 hours and discharge. Inhospital mortality did not differ according to gender, whatever the age group and use of an IS. At 3 years, overall and post-discharge mortality were similar in men and women. However, IS was associated with lower 3-year mortality (women: HR=0.54; 95% CI: 0.41-0.70; men: HR=0.50; 95% CI: 0.39-0.63) and there was no gender-strategy interaction. Conclusion: Invasive strategy remains less frequently used in women than in men, yet is associated with improved three-year survival irrespective of gender. Whether reducing the gender gap in its use would translate into a higher survival in women remains an open question.
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Assessing renal function in acute coronary syndromes: does it really matter how we do it? Results: The mean age of patients was 68±13 years and 67.5% were male. Approximately one third of study population (30.5%) had diabetes, 35.6% were elderly and 74.5% had hypertension. Regarding type of ACS, 39.5% of patients had ST elevation; 29.8% of patients reached the primary endpoint in the follow up. Mean admission creatinine was 1.22±0.87mg/dL. Mean eGFR was 70.82±25.91mL/min/1.73m 2 and mean CrCl was 70.87±32.98mL/min. Using MDRD equation, 6.7% of patients had eGFR<30.0mL/min/1.73m 2 ; otherwise, using CG formula, 9.0% of patients had CrCl<30.0mL/min. Comparing both equation the Concordance Correlation Coefficient was k=0.629 and Spearman Correlation Coefficient was 0.872, with great discrepancy for higher eGFR values. Area under the curve (AUC) of MDRD ROC curve was 0.613 (0.586; 0.639), p<0.001, while AUC of CG curve was 0.614 (0.587; 0.640), p<0.001. Comparing both ROC curves p value was not statistically different (0.888).
